•  Summary 
  •  Actions 
  •  Committee Votes 
  •  Floor Votes 
  •  Memo 
  •  Text 
  •  LFIN 
  •  Chamber Video/Transcript 

AB9552 Text:

                STATE OF NEW YORK
                   IN ASSEMBLY
                                    January 23, 2018
        Introduced  by  M.  of  A. L. ROSENTHAL -- read once and referred to the
          Committee on Social Services
        AN ACT to amend the social services law, in relation to requiring  home-
          less  shelters  to keep an opioid antagonist on hand and have at least
          one trained employee on duty at all times
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
     1    Section 1. Article 2-A of the social services law is amended by adding
     2  a new title 3 to read as follows:
     3                                   TITLE 3
     5  Section 47. Opioid antagonist use and training.
     6    § 47. Opioid antagonist use and training. 1. Any provider of temporary
     7  housing assistance, which shall include, but not be limited to, a family
     8  shelter, a shelter for adults, a hotel, an emergency apartment, a domes-
     9  tic  violence  shelter,  a runaway and homeless youth shelter, or a safe
    10  house for refugees operating in this state shall have at its premises at
    11  all times:
    12    (a) an opioid antagonist and a method  of  administering  it  on  site
    13  which may include, but not be limited to, a naloxone kit; and
    14    (b)  at  a  minimum,  one employee trained in the administration of an
    15  opioid antagonist on duty at all times.
    16    2. All employees of providers of temporary public  housing  assistance
    17  who are authorized to administer an opioid antagonist shall:
    18    (a)  have  completed  an initial training program, which may include a
    19  department of health  registered  opioid  overdose  prevention  training
    20  program;
    21    (b) complete a refresher training program at least every two years;
    22    (c)  contact  the  emergency  medical  system during any response to a
    23  victim of suspected drug overdose and advise if an opioid antagonist  is
    24  being used;
    25    (d)  comply  with  protocols for response to victims of suspected drug
    26  overdose; and
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.

        A. 9552                             2
     1    (e) report all responses to victims of suspected drug overdose to  the
     2  department of health.
     3    3.  For the purposes of this subdivision, the term "opioid antagonist"
     4  shall mean a federal food and drug  administration-approved  drug  that,
     5  when  administered, negates or neutralizes in whole or in part the phar-
     6  macological effects of an opioid in the body  and  that  is  limited  to
     7  naloxone  or  other medications approved by the department of health for
     8  this purpose and "naloxone kit" shall mean a prefilled naloxone  syringe
     9  or needle-free intranasal drug delivery device.
    10    4.  The commissioner is authorized to promulgate rules and regulations
    11  necessary for the implementation of this title.
    12    § 2. This act shall take effect on the thirtieth day  after  it  shall
    13  have  become  a  law; provided, however, that effective immediately, the
    14  addition, amendment and/or repeal of any rule  or  regulation  necessary
    15  for  the implementation of this act on its effective date are authorized
    16  to be made and completed on or before such effective date.
Go to top